Viral bronchiolitis

Todd A Florin, Amy C Plint, Joseph J Zorc, Todd A Florin, Amy C Plint, Joseph J Zorc

Abstract

Viral bronchiolitis is a common clinical syndrome affecting infants and young children. Concern about its associated morbidity and cost has led to a large body of research that has been summarised in systematic reviews and integrated into clinical practice guidelines in several countries. The evidence and guideline recommendations consistently support a clinical diagnosis with the limited role for diagnostic testing for children presenting with the typical clinical syndrome of viral upper respiratory infection progressing to the lower respiratory tract. Management is largely supportive, focusing on maintaining oxygenation and hydration of the patient. Evidence suggests no benefit from bronchodilator or corticosteroid use in infants with a first episode of bronchiolitis. Evidence for other treatments such as hypertonic saline is evolving but not clearly defined yet. For infants with severe disease, the insufficient available data suggest a role for high-flow nasal cannula and continuous positive airway pressure use in a monitored setting to prevent respiratory failure.

Copyright © 2017 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Typical clinical course and pathophysiology of viral bronchiolitis
Figure 2
Figure 2
Meta-analysis of studies assessing average clinical score after treatment in patients with bronchiolitis receiving bronchodilators versus placebo Test for heterogeneity in the inpatient studies demonstrated low inconsistency between the nine studies (I2=36%; p=0·13) and the summary effect was not significant (Z=1·06; p=0·29), the outpatient studies demonstrated very high inconsistency between the 12 studies (I2=81%; p<0·00001) and the summary effect was significant (Z=2·26; p=0·024), and the overall heterogeneity of the meta-analysis demonstrated high inconsistency between the 21 studies (I2=73%; p<0·00001) and the overall summary effect was significant (Z=2·4; p=0·016). IPR=ipratropium. SAL=salbutamol. neb=nebulised. Reproduced from Gadomski and Scribani, by permission of John Wiley and Sons.
Figure 3
Figure 3
Meta-analysis of studies assessing hospital length of stay in patients with bronchiolitis receiving nebulised 3% hypertonic saline versus control Significant difference in length of hospital stay was found in those receiving hypertonic saline compared with control; however, the largest trials had negative results, making it challenging to provide definitive conclusions regarding use of hypertonic saline in bronchiolitis. Reproduced from Maguire and colleagues, under the CC BY 4.0 Creative Commons license: http://creativecommons.org/licenses/by/4.0/.
Figure 4
Figure 4
Meta-analysis of studies assessing admission to hospital on day 1 and day 7 in patients with bronchiolitis receiving corticosteroids versus placebo Test for heterogeneity in studies assessing admission at day 1 demonstrated very low inconsistency between the ten studies (I2=0%; p=0·55) and the summary effect was not significant (Z=1·05; p=0·30), and studies assessing admission at day 7 demonstrated low inconsistency between the six studies (I2=32%; p=0·21) and the summary effect was not significant (Z=1·38; p=0·17). G=glucocorticoid. P=placebo. S=salbutamol. E=epinephrine. Reproduced from Fernandes and colleagues, by permission of John Wiley and Sons.

References

    1. Kyu HH, Pinho C, Wagner JA. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the Global Burden of Disease 2013 Study. JAMA Pediatr. 2016;170:267–287.
    1. Nair H, Nokes DJ, Gessner BD. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–1555.
    1. Pfuntner A, Wier L, Stocks C. Most frequent conditions in US hospitals, 2010. HCUP Statistical Brief #148. 2013. (accessed March 30, 2016).
    1. Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA., Jr Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010. Pediatr Infect Dis J. 2014;33:11–18.
    1. Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA., Jr Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics. 2013;132:28–36.
    1. Haynes AK, Prill MM, Iwane MK, Gerber SI. Respiratory syncytial virus—United States, July 2012–June 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1133–1136.
    1. Haynes AK, Manangan AP, Iwane MK. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis. 2013;208(suppl 3):S246–S254.
    1. Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72.
    1. Foxman EF, Storer JA, Fitzgerald ME. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci USA. 2015;112:827–832.
    1. Salah B, Dinh Xuan AT, Fouilladieu JL, Lockhart A, Regnard J. Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur Respir J. 1988;1:852–855.
    1. Wang VJ, Cavagnaro CS, Clark S, Camargo CA, Jr, Mansbach JM. Altitude and environmental climate effects on bronchiolitis severity among children presenting to the emergency department. J Environ Health. 2012;75:8–15.
    1. Yusuf S, Piedimonte G, Auais A. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007;135:1077–1090.
    1. Darrow LA, Klein M, Flanders WD, Mulholland JA, Tolbert PE, Strickland MJ. Air pollution and acute respiratory infections among children 0–4 years of age: a 1–8 year time-series study. Am J Epidemiol. 2014;180:968–977.
    1. Kim BJ, Seo JH, Jung YH. Air pollution interacts with past episodes of bronchiolitis in the development of asthma. Allergy. 2013;68:517–523.
    1. Rice MB, Rifas-Shiman SL, Oken E. Exposure to traffic and early life respiratory infection: a cohort study. Pediatr Pulmonol. 2014 doi: 10.1002/ppul.23029. published online March 27.
    1. DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ. Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr. 2012;12:81.
    1. Bradley JP, Bacharier LB, Bonfiglio J. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115:e7–14.
    1. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J. 2012;31:5–9.
    1. Hall CB, Weinberg GA, Blumkin AK. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132:e341–e348.
    1. Schuurhof A, Bont L, Siezen CL. Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls. Pediatr Pulmonol. 2010;45:608–613.
    1. Ali S, Plint AC, Klassen TP. Bronchiolitis. In: Wilmott RW, Kendig EL, Boat TF, Bush A, Chernick V, editors. Kendig and Chernick's disorders of the respiratory tract in children. 8th edn. Elsevier Saunders; Philadelphia: 2012. pp. 443–452.
    1. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23:7–18.
    1. Mansbach JM, Camargo CA., Jr Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics. 2008;122:177–179.
    1. Calvo C, Pozo F, Garcia-Garcia ML. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr. 2010;99:883–887.
    1. Midulla F, Scagnolari C, Bonci E. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child. 2010;95:35–41.
    1. Marguet C, Lubrano M, Gueudin M. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One. 2009;4:e4596.
    1. Miller EK, Gebretsadik T, Carroll KN. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J. 2013;32:950–955.
    1. Skjerven HO, Megremis S, Papadopoulos NG, Mowinckel P, Carlsen KH, Lodrup Carlsen KC. Virus type and genomic load in acute bronchiolitis: severity and treatment response with inhaled adrenaline. J Infect Dis. 2016;213:915–921.
    1. Mansbach JM, McAdam AJ, Clark S. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008;15:111–118.
    1. Mansbach JM, Piedra PA, Teach SJ. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012;166:700–706.
    1. Hasegawa K, Jartti T, Mansbach JM. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis. 2015;211:1550–1559.
    1. Scagnolari C, Midulla F, Selvaggi C. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol. 2012;201:311–317.
    1. Papadopoulos NG, Moustaki M, Tsolia M. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165:1285–1289.
    1. Semple MG, Cowell A, Dove W. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191:382–386.
    1. Jansen RR, Wieringa J, Koekkoek SM. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011;49:2631–2636.
    1. Hasegawa K, Linnemann RW, Avadhanula V. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015;8:718.
    1. Self WH, Williams DJ, Zhu Y. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis. 2016;213:584–591.
    1. Bronchiolitis in children: diagnosis and management NICE guideline. 2015. (accessed March 30, 2016).
    1. Ralston SL, Lieberthal AS, Meissner HC. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134:e1474–e1502.
    1. Court SD. The definition of acute respiratory illnesses in children. Postgrad Med J. 1973;49:771–776.
    1. Plint AC, Grenon R, Klassen TP, Johnson DW. Bronchodilator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments. CJEM. 2015;17:46–53.
    1. Fernandes RM, Plint AC, Terwee CB. Validity of bronchiolitis outcome measures. Pediatrics. 2015;135:e1399–e1408.
    1. McCallum GB, Morris PS, Wilson CC. Severity scoring systems: are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis? Pediatr Pulmonol. 2013;48:797–803.
    1. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006;48:441–447.
    1. Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19:485–498.
    1. Scottish Intercollegiate Guidelines Network (SIGN) Bronchiolitis in children: a national clinical guideline. 2006. (accessed March 30, 2016).
    1. Baraldi E, Lanari M, Manzoni P. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65.
    1. Working Group of the Clinical Practice Guideline on Acute Bronchiolitis. Quality plan for the Spanish national healthcare system of the Spanish Ministry for Health and Social Policy; Catalan Agency for Health Technology Assessment, 2010. Clinical Practice Guidelines in the Spanish National Healthcare System: CAHTA no. 2007/05.
    1. Turner T, Wilkinson F, Harris C, Mazza D. Evidence based guidelines for the management of bronchiolitis. Aust Fam Physician. 2008;37:6–13.
    1. Verstraete M, Cros P, Gouin M. Prise en charge de la bronchiolite aiguë du nourrisson de moins 1 an: actualization et consensus medical au sein des hôpitaux universitaires du Grand Ouest (HUGO) Arch Pediatr. 2014;21:53–62.
    1. Schuh S, Freedman S, Coates A. Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial. JAMA. 2014;312:712–718.
    1. Cunningham S, Rodriguez A, Adams T. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015;386:1041–1048.
    1. McCulloh R, Koster M, Ralston S. Use of intermittent vs continuous pulse oximetry for non-hypoxemic infants and young children hospitalized for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2015;169:898–904.
    1. Principi T, Coates AL, Parkin PC, Stephens D, DaSilva Z, Schuh S. Effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis. JAMA Pediatr. 2016;170:602–608.
    1. Mahabee-Gittens EM, Bachman DT, Shapiro ED, Dowd MD. Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila) 1999;38:395–399.
    1. Mathews B, Shah S, Cleveland RH, Lee EY, Bachur RG, Neuman MI. Clinical predictors of pneumonia among children with wheezing. Pediatrics. 2009;124:e29–e36.
    1. Ecochard-Dugelay E, Beliah M, Perreaux F. Clinical predictors of radiographic abnormalities among infants with bronchiolitis in a paediatric emergency department. BMC Pediatr. 2014;14:143.
    1. Schuh S, Lalani A, Allen U. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr. 2007;150:429–433.
    1. Ecochard-Dugelay E, Beliah M, Boisson C. Impact of chest radiography for children with lower respiratory tract infection: a propensity score approach. PLoS One. 2014;9:e96189.
    1. Mahabee-Gittens EM, Dowd MD, Beck JA, Smith SZ. Clinical factors associated with focal infiltrates in wheezing infants and toddlers. Clin Pediatr (Phila) 2000;39:387–393.
    1. Caiulo VA, Gargani L, Caiulo S. Lung ultrasound in bronchiolitis: comparison with chest X-ray. Eur J Pediatr. 2011;170:1427–1433.
    1. Basile V, Di Mauro A, Scalini E. Lung ultrasound: a useful tool in diagnosis and management of bronchiolitis. BMC Pediatr. 2015;15:63.
    1. Stollar F, Alcoba G, Gervaix A, Argiroffo CB. Virologic testing in bronchiolitis: does it change management decisions and predict outcomes? Eur J Pediatr. 2014;173:1429–1435.
    1. Nenna R, Ferrara M, Nicolai A. Viral load in infants hospitalized for respiratory syncytial virus bronchiolitis correlates with recurrent wheezing at thirty-six-month follow-up. Pediatr Infect Dis J. 2015;34:1131–1132.
    1. Hall CB. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis. 2007;45:353–359.
    1. Fabian M, McDevitt J, Milton D. Modes of transmission of respiratory viral infections. In: Johnston SL, O'Byrne P, eds. Exacerbations of asthma. Boston: exposure, epidemiology risk program. Department of Environmental Health Harvard School of Public Health, 2005: 2007: 1–2.
    1. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257–265.
    1. Levine DA, Platt SL, Dayan PS. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113:1728–1734.
    1. Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2007;26:311–315.
    1. Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr. 2014;4:33–38.
    1. Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis a systematic review. Arch Pediat Adol Med. 2011;165:951–956.
    1. Elkhunovich MA, Wang VJ. Assessing the utility of urine testing in febrile infants aged 2 to 12 months with bronchiolitis. Pediatr Emerg Care. 2015;31:616–620.
    1. Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–610.
    1. Mazur NI, Martinón-Torres F, Baraldi E. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3:888–900.
    1. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6 CD001266.
    1. Hartling L, Bialy LM, Vandermeer B. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6 CD003123.
    1. Skjerven HO, Hunderi JO, Brugmann-Pieper SK. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med. 2013;368:2286–2293.
    1. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol. 2010;45:36–40.
    1. Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99:9–13.
    1. Donaldson SH. Hydrator therapies for cystic fibrosis lung disease. Pediatric Pulmonology. 2008;43:S18–S23.
    1. Mandelberg A, Tal G, Witzling M. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123:481–487.
    1. Kuzik BA, Al-Qadhi SA, Kent S. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151:266–270.
    1. Luo Z, Liu E, Luo J. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int. 2010;52:199–202.
    1. Wu S, Baker C, Lang ME. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2014;168:657–663.
    1. Florin TA, Shaw KN, Kittick M, Yakscoe S, Zorc JJ. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. JAMA Pediatr. 2014;168:664–670.
    1. Grewal S, Klassen TP. The tale of 2 trials: disentangling contradictory evidence on hypertonic saline for acute bronchiolitis. JAMA Pediatr. 2014;168:607–609.
    1. Silver AH, Esteban-Cruciani N, Azzarone G. 3% hypertonic saline versus normal saline in inpatient bronchiolitis: a randomized controlled trial. Pediatrics. 2015;136:1036–1043.
    1. Flores P, Mendes AL, Neto AS. A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediatr Pulmonol. 2016;51:418–425.
    1. Everard ML, Hind D, Ugonna K. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax. 2014;69:1105–1112.
    1. Teunissen J, Hochs AH, Vaessen-Verberne A. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J. 2014;44:913–921.
    1. Zhang L, Mendoza-Sassi RA, Klassen TP, Wainwright C. Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics. 2015;136:687–701.
    1. Maguire C, Cantrill H, Hind D, Bradburn M, Everard ML. Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med. 2015;15:148.
    1. Brooks CG, Harrison WN, Ralston SL. Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis: a reanalysis of 2 meta-analyses. JAMA Pediatr. 2016;170:577–584.
    1. Corneli HM, Zorc JJ, Mahajan P. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357:331–339.
    1. Plint AC, Johnson DW, Patel H. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360:2079–2089.
    1. Fernandes RM, Bialy LM, Vandermeer B. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;6 CD004878.
    1. Sinha IP, McBride AK, Smith R, Fernandes RM. CPAP and high-flow nasal cannula oxygen in bronchiolitis. Chest. 2015;148:810–823.
    1. Bueno Campana M, Olivares Ortiz J, Notario Munoz C. High flow therapy versus hypertonic saline in bronchiolitis: randomised controlled trial. Arch Dis Child. 2014;99:511–515.
    1. Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014;10 CD005189.
    1. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics. 1998;101:617–619.
    1. Shazberg G, Revel-Vilk S, Shoseyov D, Ben-Ami A, Klar A, Hurvitz H. The clinical course of bronchiolitis associated with acute otitis media. Arch Dis Child. 2000;83:317–319.
    1. Lieberthal AS, Carroll AE, Chonmaitree T. The diagnosis and management of acute otitis media. Pediatrics. 2013;131:e964–e999.
    1. McCallum GB, Morris PS, Chatfield MD. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. PLoS One. 2013;8:e74316.
    1. Pinto LA, Pitrez PM, Luisi F. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial. J Pediatr. 2012;161:1104–1108.
    1. Beigelman A, Isaacson-Schmid M, Sajol G. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2015;135:1171–1178.
    1. Bacharier LB, Guilbert TW, Mauger DT. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial. JAMA. 2015;314:2034–2044.
    1. Oakley E, Borland M, Neutze J, for the Paediatric Research in Emergency Departments International Collaborative (PREDICT) Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial. Lancet Respir Med. 2013;1:113–120.
    1. Mussman GM, Parker MW, Statile A, Sucharew H, Brady PW. Suctioning and length of stay in infants hospitalized with bronchiolitis. JAMA Pediatr. 2013;167:414–421.
    1. Moschino L, Mario F, Carraro S, Visentin F, Zanconato S, Baraldi E. Is nasal suctioning warranted before measuring O2 saturation in infants with bronchiolitis? Arch Dis Child. 2016;101:114–115.
    1. Schreiber S, Ronfani L, Ghirardo S. Nasal irrigation with saline solution significantly improves oxygen saturation in infants with bronchiolitis. Acta Paediatr. 2016;105:292–296.
    1. Ralston S, Garber M, Narang S. Decreasing unnecessary utilization in acute bronchiolitis care: results from the value in inpatient pediatrics network. J Hosp Med. 2013;8:25–30.
    1. Gajdos V, Katsahian S, Beydon N. Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial. PLoS Med. 2010;7:e1000345.
    1. Roqué i Figuls M, Giné-Garriga M, Granados Rugeles C, Perrotta C, Vilaró J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016;2 CD004873.
    1. Carlsen KH, Larsen S, Bjerve O, Leegaard J. Acute bronchiolitis: predisposing factors and characterization of infants at risk. Pediatr Pulmonol. 1987;3:153–160.
    1. Sigurs N, Aljassim F, Kjellman B. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65:1045–1052.
    1. Stein RT, Sherrill D, Morgan WJ. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545.
    1. Fjaerli HO, Farstad T, Rod G, Ufert GK, Gulbrandsen P, Nakstad B. Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr. 2005;5:31.
    1. Jeng MJ, Lee YS, Tsao PC, Yang CF, Soong WJ. A longitudinal study on early hospitalized airway infections and subsequent childhood asthma. PLoS One. 2014;10:e0121906.
    1. Carroll KN, Wu P, Gebretsadik T. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol. 2009;123:1055. 61.e1.
    1. Everard ML, Hind D, Ugonna K. Saline in acute bronchiolitis RCT and economic evaluation: hypertonic saline in acute bronchiolitis—randomised controlled trial and systematic review. Health Technol Assess. 2015;19:1–130.
    1. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994;344:219–224.
    1. Pauwels RA, Lofdahl CG, Postma DS. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337:1405–1411.
    1. Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Respir J. 2007;29:587–595.
    1. Giembycz MA, Kaur M, Leigh R, Newton R. A holy grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol. 2008;153:1090–1104.
    1. Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting beta 2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol. 2008;73:203–214.
    1. Holden NS, Bell MJ, Rider CF. Beta 2-adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proc Natl Acad Sci USA. 2011;108:19713–19718.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa